Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
IVF hartmann Holding AGXSWX:VBSN -1.51%74 5-Year Yield-on-Cost % is 3.95 as of Jul. 17, 2026, which is 74% above its 10-year median of 2.27. GuruFocus rates XSWX:VBSN with a GF Score™ of 74/100 and a GF Value™ of CHF143.30 (Fairly Valued). Among 325 Medical Devices & Instruments companies, IVF hartmann Holding AG ranks better than 70.15% on this metric.
The historical rank and industry rank for IVF hartmann Holding AG's 5-Year Yield-on-Cost % or its related term are showing as below:
XSWX:VBSN'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.43 Med: 2.27 Max: 4.02
Current: 3.95
During the past 13 years, IVF hartmann Holding AG's highest Yield on Cost was 4.02. The lowest was 1.43. And the median was 2.27.
XSWX:VBSN's 5-Year Yield-on-Cost % is ranked better than 70.15% of 325
companies
in the Medical Devices & Instruments industry
Industry Median: 2.34
vs XSWX:VBSN: 3.95
IVF hartmann Holding AG (XSWX:VBSN) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
IVF hartmann Holding AG 5-Year Yield-on-Cost % Related Terms
XSWX:VBSN vs ISRG, BDX, MDLN: 5-Year Yield-on-Cost % Comparison
For the Medical Instruments & Supplies subindustry, IVF hartmann Holding AG's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IVF hartmann Holding AG 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, IVF hartmann Holding AG's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where IVF hartmann Holding AG's 5-Year Yield-on-Cost % falls into.
IVF hartmann Holding AG 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
IVF hartmann Holding AG (XSWX:VBSN) has a 5-Year Yield-on-Cost % of 3.95 as of Jul. 17, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on IVF hartmann Holding AG and its competitors. This is 74% above median its historical median of 2.27. Over the past decade, IVF hartmann Holding AG's 5-Year Yield-on-Cost % has ranged from 1.43 to 4.02. According to the industry distribution chart, IVF hartmann Holding AG ranks #97 out of 325 companies in the Medical Devices & Instruments industry, placing it in the top 29.8%.
Is IVF hartmann Holding AG's 5-Year Yield-on-Cost % too high?
IVF hartmann Holding AG's current 5-Year Yield-on-Cost % of 3.95 is 74% above median its 10-year median of 2.27. Over the past 10 years, this metric has ranged from a low of 1.43 to a high of 4.02. The Medical Devices & Instruments industry median 5-Year Yield-on-Cost % is 2.34. IVF hartmann Holding AG's value of 3.95 is 68.8% above this industry median. Based on the distribution chart, IVF hartmann Holding AG ranks #97 out of 325 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, IVF hartmann Holding AG has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does IVF hartmann Holding AG's 5-Year Yield-on-Cost % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, IVF hartmann Holding AG ranks #97 out of 325 companies for 5-Year Yield-on-Cost %. This puts IVF hartmann Holding AG in the upper half of its industry. The industry median 5-Year Yield-on-Cost % is 2.34. IVF hartmann Holding AG's value of 3.95 is 68.8% above this benchmark. Historically, IVF hartmann Holding AG's own 5-Year Yield-on-Cost % has ranged from 1.43 to 4.02 over the past decade. While the company's 10-year median is 2.27 vs. the industry median of 2.34, IVF hartmann Holding AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.34, based on 325 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. IVF hartmann Holding AG's current 5-Year Yield-on-Cost % of 3.95 is 68.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on IVF hartmann Holding AG and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.34 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. IVF hartmann Holding AG's current 5-Year Yield-on-Cost % is 3.95, which is 74% above median its own 10-year median of 2.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IVF hartmann Holding AG stock overvalued right now?
Based on GuruFocus' analysis, IVF hartmann Holding AG (XSWX:VBSN) is currently considered Fairly Valued. The stock's GF Value™ is CHF143.30, compared to a current price of CHF130.50 — trading 8.9% below its estimated fair value. The current 5-Year Yield-on-Cost % is 3.95, which is 74% above median its 10-year median of 2.27 and 68.8% above the Medical Devices & Instruments industry median of 2.34. IVF hartmann Holding AG's overall GF Score™ is 74/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For IVF hartmann Holding AG (XSWX:VBSN), the current 5-Year Yield-on-Cost % is 3.95 as of Jul. 17, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is IVF hartmann Holding AG (XSWX:VBSN) Overvalued in 2026?
Based on GuruFocus' analysis, IVF hartmann Holding AG stock appears to be undervalued.
The current stock price of CHF130.50 is trading 8.9% below its estimated GF Value™ of CHF143.30.
GuruFocus considers IVF hartmann Holding AG to be Fairly Valued.
Key valuation signals for XSWX:VBSN:
5-Year Yield-on-Cost %: 3.95 (74% above median its 10-year median of 2.27)
GF Value™: CHF143.30 vs. price of CHF130.50 (8.9% below fair value)
Industry Position: 68.8% above the Medical Devices & Instruments median (#97 of 325)
No single metric tells the full story. See the XSWX:VBSN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
IVF hartmann Holding AG engages in production and supply of medical, pharmaceutical and hygiene products in Switzerland, it offers products such as surgical disposable, disposable dental, first aid, therapeutic plaster, cotton wool, wound care among others. The company operates in four segment wound care, incontinence management, infection management and Other group activities.
74GF Score
Get the complete analysis for XSWX:VBSN
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:VBSN has been successfully added to your 
